Halo Nevus: When Your Mole Develops a White Ring Around It

A halo nevus — also known as a Sutton nevus, leukoderma acquisitum centrifugum, or perinevoid vitiligo — is a melanocytic nevus (mole) that is surrounded by a symmetric ring (halo) of depigmented (white) skin. This striking appearance results from an immune-mediated process in which the body's own T lymphocytes attack and destroy the melanocytes — the pigment-producing cells — both within the mole and in the surrounding normal skin. Halo nevi are remarkably common, affecting approximately one percent of the general population, though the true incidence is likely higher as many go unnoticed or unreported.

They are most commonly seen in children and teenagers, with a peak incidence during adolescence, though they can develop at any age. Halo nevi occur with equal frequency in males and females and are observed across all ethnicities. The back is the most common location, followed by the trunk and extremities.

While the white ring typically surrounds a pre-existing mole, halo nevi can also develop around congenital nevi or other melanocytic lesions. The central mole may be flat or raised, brown, pink, or skin-colored. In most cases, the process progresses over months to years: the white halo develops first, then the central mole gradually fades and disappears, leaving a round area of white skin that eventually repigments to match the surrounding skin.

This entire cycle can take several years to complete. Halo nevi are overwhelmingly benign and represent the immune system functioning normally — indeed, overenthusiastically — against melanocytic cells.

The white halo surrounding a halo nevus is the visible result of a targeted immune attack against melanocytes. Research has revealed that the depigmented ring is created by cytotoxic T lymphocytes (CD8-positive T cells) that recognize melanocyte-specific antigens as foreign or abnormal and mount a cell-mediated immune response to destroy them. These T cells infiltrate the nevus and surrounding skin, releasing cytokines and directly killing melanocytes through perforin and granzyme-mediated pathways.

The process is essentially identical to the mechanism that destroys melanocytes in vitiligo, but in a halo nevus, the immune attack is focused on and around a specific melanocytic lesion. Several theories explain why the immune system targets these particular melanocytes. The most widely accepted hypothesis is that nevus melanocytes express aberrant antigens on their surface — proteins that differ from those on normal melanocytes — which are recognized as foreign by the immune system.

These altered antigens may result from the accumulated mutations that caused the melanocytes to form a nevus in the first place. Another theory proposes that the immune system is correctly identifying and eliminating pre-malignant or abnormal melanocytes — essentially performing a beneficial surveillance function. Supporting this theory, studies have found that some halo nevi contain melanocytes with mild dysplastic features.

Regardless of the precise trigger, the immune response is real and measurable: biopsies of halo nevi show a dense band-like infiltrate of lymphocytes, and the melanocytes within and around the nevus show evidence of immune-mediated destruction. This is fundamentally a healthy immune process, not a disease.

Halo nevi and vitiligo share a fundamental mechanism — both involve immune-mediated destruction of melanocytes — and the clinical association between these two conditions is well established. Individuals who develop halo nevi have a higher incidence of vitiligo than the general population, and patients with vitiligo more frequently have or develop halo nevi. Studies have found that approximately 15 to 25 percent of vitiligo patients have concurrent halo nevi, compared to approximately one percent of the general population.

The shared mechanism involves autoimmune recognition of melanocyte-specific antigens, including tyrosinase, Melan-A (MART-1), gp100 (Pmel17), and TRP-1 and TRP-2, all of which are proteins involved in melanin production. In vitiligo, this immune attack is widespread and progressive, leading to expanding patches of depigmented skin. In a halo nevus, the identical process is focused on a single melanocytic lesion and its immediate surroundings.

Some dermatologists consider halo nevi to be a localized, self-limiting form of vitiligo focused on a melanocytic target. The practical implication is that a child or teenager who develops halo nevi — especially multiple simultaneous halo nevi — should be monitored for signs of vitiligo development, which may appear months or years later. Similarly, halo nevi may also be associated with other autoimmune conditions that cluster with vitiligo, including thyroid disease (particularly Hashimoto's thyroiditis and Graves' disease), type 1 diabetes, pernicious anemia, and Addison's disease.

This does not mean that having a halo nevus guarantees you will develop any of these conditions — most people with halo nevi never develop vitiligo or other autoimmune disease. But awareness of the association allows for appropriate monitoring.

The overwhelming majority of halo nevi are completely benign, and in children and teenagers, they rarely require anything beyond observation and reassurance. However, certain clinical scenarios warrant closer evaluation. In adults over the age of 40 developing a new halo nevus, heightened vigilance is appropriate because the halo phenomenon can occasionally occur around a melanoma — the immune system recognizing and attacking the malignant melanocytes.

While this immune response against melanoma is actually favorable (regression of melanoma carries a better prognosis than non-regression in some contexts), the central lesion still needs evaluation. Any halo nevus where the central mole is asymmetric, has irregular borders, shows multiple colors, or is larger than six millimeters should be evaluated with dermoscopy and potentially biopsied. Halo nevi with eccentric (off-center) halos or irregular, asymmetric halos rather than the typical uniform, symmetric ring deserve professional assessment.

Multiple simultaneous halo nevi developing in an adult should prompt a thorough full-body skin examination to rule out an occult melanoma elsewhere on the body — sometimes the immune activation that causes multiple halo nevi is triggered by a melanoma at a distant site, and the halo phenomenon represents an immune cross-reaction against melanocyte antigens.!! This association is uncommon but clinically important. If the central mole within a halo nevus does not follow the expected pattern of gradual, symmetric fading, or if it becomes darker, grows, develops nodularity, or bleeds, biopsy is warranted. Similarly, if the white halo progresses to involve much larger areas of skin beyond the immediate perinevoid zone, this may represent developing vitiligo and warrants dermatologic assessment.

The natural course of a halo nevus follows a predictable sequence that typically spans several years. Stage one involves the development of the white depigmented halo around an existing mole, usually appearing gradually over weeks to months. Stage two sees the central mole begin to flatten and fade, losing pigmentation as the immune-mediated destruction of melanocytes progresses.

Stage three involves complete disappearance of the central mole, leaving a round patch of depigmented white skin. Stage four, the final phase, involves gradual repigmentation of the white area as new melanocytes migrate from the periphery and hair follicles, eventually restoring the area to near-normal or normal skin color. This entire process can take anywhere from two to ten years or more, and some halo nevi remain in an intermediate stage indefinitely without completing the full cycle.

Management of typical halo nevi is straightforward: clinical observation with reassurance. No treatment is needed for the halo nevus itself. In children and teenagers with a classic presentation — a symmetric mole with a symmetric white ring, stable or progressively fading — clinical monitoring alone is appropriate, with follow-up examinations every six to twelve months to confirm the expected benign progression.

Documentation with clinical photographs at each visit helps track changes objectively. The depigmented halo area should be protected from sun exposure, as the lack of melanocytes means the skin in that area is more vulnerable to UV damage and sunburn.!! Broad-spectrum sunscreen should be applied to the depigmented zone. If removal of a halo nevus is desired for cosmetic reasons or diagnostic certainty, excisional biopsy including the central nevus and a portion of the halo is recommended.

Noticing a white ring developing around a mole can be unsettling — it looks abnormal and different from anything you have seen before. Skinscanner provides immediate context and analysis when you photograph a mole with a surrounding depigmented halo. The AI evaluates the central mole's characteristics — its symmetry, border regularity, color uniformity, and size — as well as the halo pattern — its symmetry, width, and regularity — to determine whether the presentation matches the typical benign pattern of a halo nevus or displays atypical features warranting professional assessment.

This is particularly reassuring for parents who discover a halo nevus on their child and need guidance on whether it is cause for concern. Skinscanner can help distinguish a classic halo nevus from other conditions that can create a depigmented ring around a skin lesion, including melanoma with regression and halo phenomenon around a dysplastic nevus. For individuals with known halo nevi, regular scanning tracks the evolution through the expected stages — halo development, mole fading, complete regression, and repigmentation — providing visual documentation that confirms normal progression or flags any deviation from the expected pattern.

Skinscanner does not replace dermatoscopic evaluation, which provides magnified subsurface detail that standard photography cannot capture. Any atypical halo nevus — particularly in adults — should be examined professionally with dermoscopy and potentially biopsied for histologic confirmation. But for initial assessment and ongoing monitoring of typical halo nevi, Skinscanner offers accessible, informed guidance.